Phio Pharmaceuticals Corp.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PHIO | MDMA.CN | QPT.V | OSTX | BCTX | PMCB | |
|---|---|---|---|---|---|---|
| Market cap | 10.11M | 17.63M | 4.23M | 53.83M | 27.86M | 4.09M |
| P/E (TTM) | — | — | 0.8 | — | — | — |
| Forward P/E | -1.4 | — | — | 3.3 | -8.2 | -1.0 |
| Price/book | 0.8 | 8.9 | 0.2 | -4.4 | 1.7 | 0.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −41.22% | +28.00% | −25.00% | −35.56% | −67.55% | −61.58% |
| Today | −3.67% | −15.79% | 0.00% | −0.86% | +5.98% | +12.03% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All PHIO news ›Phio Pharmaceuticals Announces Successful Completion of First Commercial-Scale cGMP Batch of PH-762 Drug Substance
The batch met established specifications and quality requirements, confirmed by Certificates of Analysis and Compliance. Phio Pharmaceuticals (PHIO) has released its first commercial-scale batch of PH-762 drug substance, completing a…
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
October 19, 2026 9:53 AM EDT | Source: Phio Pharmaceuticals Corp. "We look forward to engaging with investors at the Renmark Financial Virtual Non-Deal Roadshow to highlight Phio's differentiated siRNA therapeutic platform which is…
Phio Pharmaceuticals releases first PH-762 batch
3 E Network Signs Core 9 MVA Power Distribution Agreement for Mikkeli AI Compute Center in Finland J-Star Holding Co., Ltd. Advances U.S. Drone Manufacturing Initiative; Negotiates Acquisition of Facility in the Greater Houston Area Merck…
More from 1 other outlet
Phio Pharmaceuticals Highlights 85% Response Rate as PH-762 Nears Phase 2b
Posted by Defense World Staff on Oct 11th, 2026 The company’s approach centers on INTASYL, a self-delivering short interfering RNA platform designed to silence specific genes. PH-762 targets PD-1, a protein that can inhibit immune-cell…
Phio Pharmaceuticals to Present at the National Investment Banking Association (NIBA) 153rd Conference
openPR.com Phio Pharmaceuticals to Present at the National Investment Banking Association (NIBA) 153rd Conference Press release from: B2i Digital, Inc. Permanent link to this press release: You c
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net4
- newsfilecorp.com2
- openpr.com2
- clinicaltrialvanguard.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.